Dr. Scott Gottlieb
American Enterprise Institute
New Enterprise Associates boosted the digital health space by funneling $40 million into insurtech Bright Health. In addition to being a partner at the venture capital firm, Gottlieb who served as commissioner of the Food and Drug Administration, also sits on the boards of Pfizer, Illumina, Aetion and Tempus. While at the FDA, Gottlieb focused on drug pricing, medical product innovation, food safety and addiction.
Gottlieb speaks: “There were failures of public health authorities, not just in how we executed, but also in how we expressed uncertainty with the public. I think that there were many moments where we expressed too much certainty and showing more humility actually would have earned more public trust.”